Spironolactone Use Not Linked to Increased Risk for Cancer
No significant associations seen for spironolactone with risk for breast, ovarian, bladder, kidney, gastric, esophageal cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.